Bvf Inc/il - Net Worth and Insider Trading
Bvf Inc/il Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bvf Inc/il owns 52 companies in total, including Five Prime Therapeutics Inc (FPRX) , Eledon Pharmaceuticals Inc (ELDN) , and XOMA Royalty Corp (XOMA) among others .
Click here to see the complete history of Bvf Inc/il’s form 4 insider trades.
Insider Ownership Summary of Bvf Inc/il
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2020-10-06 | 10 percent owner |
| ELDN | Eledon Pharmaceuticals Inc | 2020-10-01 | 10 percent owner |
| XOMA | XOMA Royalty Corp | 2017-02-10 | 10 percent owner |
 | | 2020-01-01 | 10 percent owner |
| | 2021-06-16 | other: See Explanation of Responses |
| | 2020-08-18 | 10 percent owner |
| | 2020-06-18 | 10 percent owner |
| | 2019-06-19 | 10 percent owner |
| | 2017-06-09 | 10 percent owner |
| | 2019-12-09 | 10 percent owner |
| | 2018-11-16 | 10 percent owner |
| | 2017-05-01 | 10 percent owner |
| | 2017-09-19 | 10 percent owner |
| | 2016-11-30 | 10 percent owner |
| | 2018-12-04 | 10 percent owner |
| | 2017-11-28 | 10 percent owner |
| | 2018-05-30 | 10 percent owner |
| | 2016-09-08 | 10 percent owner |
| | 2017-11-17 | 10 percent owner |
| | 2008-10-07 | 10 percent owner & other: Indirect Beneficial Owner |
| | 2017-05-08 | 10 percent owner |
| | 2016-06-23 | 10 percent owner |
| | 2012-08-28 | 10 percent owner |
| | 2009-07-09 | 10 percent owner |
| | 2008-11-06 | 10 percent owner & other: Indirect Beneficial Owners |
| | 2014-03-21 | other: See Explanation of Responses |
| | 2011-10-05 | 10 percent owner |
| | 2013-05-01 | 10 percent owner |
| | 2008-02-20 | 10 percent owner & other: Indirect Beneficial Owner |
| | 2009-12-22 | 10 percent owner |
| | 2009-12-18 | 10 percent owner |
| | 2009-10-21 | 10 percent owner |
| | 2008-10-23 | 10 percent owner & other: Indirect Beneficial Owners |
| | 2009-05-15 | 10 percent owner & other: Group Member |
| | 2009-02-03 | 10 percent owner & other: Indirect Beneficial Owners |
| | 2006-06-06 | 10 percent owner & other: Indirect Beneficial Owner |
| | 2006-01-12 | 10 percent owner & other: Indirect Beneficial Owner |
| | 2004-07-07 | 10 percent owner & other: Indirect Beneficial Owner |
| | 2003-10-27 | 10 percent owner & other: Indirect Beneficial Owner |
| | 2017-02-10 | 10 percent owner |
| | 2020-12-18 | 10 percent owner |
| | 2022-01-25 | 10 percent owner |
| | 2021-04-22 | 10 percent owner |
| | 2020-11-18 | 10 percent owner |
| | 2021-12-31 | 10 percent owner |
| | 2021-10-28 | 10 percent owner |
| | 2022-04-05 | director & 10 percent owner |
| | 2022-06-16 | 10 percent owner |
| | 2022-07-11 | 10 percent owner |
| | 2022-12-19 | 10 percent owner |
| | 2023-02-03 | 10 percent owner |
| | 2023-11-02 | 10 percent owner |
Bvf Inc/il Trading Performance
Bvf Inc/il Ownership Network
Bvf Inc/il Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and other: See Explanation of Responses Biotechnology Value Fund Ii Lp .
Five Prime Therapeutics Inc (FPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XOMA Royalty Corp do?
Who are the key executives at XOMA Royalty Corp?
Bvf Inc/il is the 10 percent owner of XOMA Royalty Corp. Other key executives at XOMA Royalty Corp include Chief Financial Officer Thomas M. Burns , director & Interim CEO Owen Hughes , and Chief Investment Officer Bradley Sitko .
XOMA Royalty Corp (XOMA) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in XOMA Royalty Corp (XOMA). Other recent insider transactions involving XOMA Royalty Corp (XOMA) include a net sale of 18,381 shares made by Owen Hughes , a net sale of 9,775 shares made by Thomas M. Burns , and a net purchase of 1,750 shares made by Bradley Sitko .
In summary, during the past 3 months, insiders sold 31,656 shares of XOMA Royalty Corp (XOMA) in total and bought 0 shares, with a net sale of 31,656 shares. During the past 18 months, 31,656 shares of XOMA Royalty Corp (XOMA) were sold and 5,250 shares were bought by its insiders, resulting in a net sale of 26,406 shares.
XOMA Royalty Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Royalty Corp Insider Transactions
- Download to Excel(.xls)
What does Merus NV do?
Who are the key executives at Merus NV?
Bvf Inc/il is the 10 percent owner of Merus NV. Other key executives at Merus NV include Chief Accounting Officer Harry Shuman , EVP & General Counsel Peter B. Silverman , and director & President & CEO & PFO Sven Ante Lundberg .
Merus NV (MRUS) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Merus NV (MRUS). Other recent insider transactions involving Merus NV (MRUS) include a net sale of 20,240 shares made by Harry Shuman , and a net sale of 94,386 shares made by Peter B. Silverman .
In summary, during the past 3 months, insiders sold 0 shares of Merus NV (MRUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,626 shares of Merus NV (MRUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114,626 shares.
Merus NV (MRUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merus NV Insider Transactions
- Download to Excel(.xls)
What does Kymera Therapeutics Inc do?
Who are the key executives at Kymera Therapeutics Inc?
Bvf Inc/il is the other: See Explanation of Responses of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Medical Officer Jared Gollob , Chief Operating Officer Jeremy G Chadwick , and 10 percent owner Atlas Venture Fund X, L.p. .
Kymera Therapeutics Inc (KYMR) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .
In summary, during the past 3 months, insiders sold 2,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 1,458,942 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,044,836 shares.
Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kymera Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Bvf Inc/il is the 10 percent owner of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include director & President & CEO Martin Babler , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does IDEAYA Biosciences Inc do?
Who are the key executives at IDEAYA Biosciences Inc?
Bvf Inc/il is the 10 percent owner of IDEAYA Biosciences Inc. Other key executives at IDEAYA Biosciences Inc include SVP & Chief Scientific Officer Michael Anthony White , director & President and CEO Yujiro S Hata , and See Remarks Briseno Andres Ruiz .
IDEAYA Biosciences Inc (IDYA) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in IDEAYA Biosciences Inc (IDYA). Other recent insider transactions involving IDEAYA Biosciences Inc (IDYA) include a net sale of 34,485 shares made by Jason Throne , a net sale of 425,000 shares made by Yujiro S Hata , and a net sale of 10,000 shares made by Briseno Andres Ruiz .
In summary, during the past 3 months, insiders sold 0 shares of IDEAYA Biosciences Inc (IDYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 510,485 shares of IDEAYA Biosciences Inc (IDYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 510,485 shares.
IDEAYA Biosciences Inc (IDYA)'s detailed insider trading history can be found in Insider Trading Tracker table.
IDEAYA Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Calithera Biosciences Inc do?
Who are the key executives at Calithera Biosciences Inc?
Bvf Inc/il is the 10 percent owner of Calithera Biosciences Inc. Other key executives at Calithera Biosciences Inc include director & 10 percent owner Deepika Pakianathan , 10 percent owner Takeda Ventures, Inc. , and SR. VP & CLINICAL DEVELOPMENT Keith Orford .
Calithera Biosciences Inc (CALA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Calithera Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Bvf Inc/il is the 10 percent owner of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
- Download to Excel(.xls)
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Bvf Inc/il is the 10 percent owner of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 323,500 shares made by Robert I Blum , a net sale of 210,749 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 75,558 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 75,558 shares. During the past 18 months, 639,849 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639,849 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
- Download to Excel(.xls)
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , 10 percent owner Bvf I Gp Llc , and other: See Explanation of Responses Bvf Ii Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 6,000 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does GlycoMimetics Inc do?
Who are the key executives at GlycoMimetics Inc?
Bvf Inc/il is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .
GlycoMimetics Inc (GLYC) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 17,500 shares made by Brian M. Hahn .
In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,271,499 shares of GlycoMimetics Inc (GLYC) were sold and 387,903 shares were bought by its insiders, resulting in a net sale of 1,883,596 shares.
GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
GlycoMimetics Inc Insider Transactions
- Download to Excel(.xls)
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .
Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.
Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Immune Design Corp do?
Who are the key executives at Immune Design Corp?
Bvf Inc/il is the 10 percent owner of Immune Design Corp. Other key executives at Immune Design Corp include 10 percent owner & other: General Partner Column Group Gp, Lp , 10 percent owner Column Group L P , and 10 percent owner & other: General Partner Ponoi Management, Llc .
Immune Design Corp (IMDZ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immune Design Corp Insider Transactions
- Download to Excel(.xls)
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 105,710 shares made by Briggs Morrison , a net sale of 83,000 shares made by William Meury , and a net purchase of 1,250 shares made by Keith A. Goldan .
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 188,710 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 187,460 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Arqule Inc do?
Who are the key executives at Arqule Inc?
Bvf Inc/il is the 10 percent owner of Arqule Inc. Other key executives at Arqule Inc include director & Chief Executive Officer Paolo Pucci , CFO and Treasurer Marc Schegerin , and See Remarks Brian Schwartz .
Arqule Inc (ARQL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc (ARQL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc (ARQL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Arqule Inc (ARQL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arqule Inc Insider Transactions
- Download to Excel(.xls)
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include Chief Financial Officer Sherry Aulin , SVP Bus. & Corp. Development Sherrington Robin , and director & PRESIDENT & CEO Ian Mortimer .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 31,467 shares made by Gary Patou , a net sale of 25,000 shares made by Dawn Svoronos , and a net sale of 18,709 shares made by Sherry Aulin .
In summary, during the past 3 months, insiders sold 23,600 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 23,600 shares. During the past 18 months, 97,405 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,405 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Capstone Holding Corp do?
Who are the key executives at Capstone Holding Corp?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owner of Capstone Holding Corp. Other key executives at Capstone Holding Corp include other: See Remarks Alimco Financial Corp , 10 percent owner Neil S Subin , and 10 percent owner Miller Lloyd I Iii .
Capstone Holding Corp (CAPS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Capstone Holding Corp (CAPS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capstone Holding Corp (CAPS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Capstone Holding Corp (CAPS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Capstone Holding Corp Insider Transactions
- Download to Excel(.xls)
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Bvf Inc/il is the 10 percent owner of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Cascadian Therapeutics Inc do?
Who are the key executives at Cascadian Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner New Enterprise Associates 15, L.p. , and 10 percent owner Jon Sakoda .
Cascadian Therapeutics Inc (CASC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cascadian Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ChemoCentryx Inc do?
Who are the key executives at ChemoCentryx Inc?
Bvf Inc/il is the 10 percent owner of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , director & 10 percent owner & President & CEO and Director Thomas J. Schall , and SVP & Finance & Acctg Officer Yi Ching Yau .
ChemoCentryx Inc (CCXI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
ChemoCentryx Inc Insider Transactions
- Download to Excel(.xls)
What does Catalyst Biosciences Inc do?
Who are the key executives at Catalyst Biosciences Inc?
Bvf Inc/il is the 10 percent owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .
Catalyst Biosciences Inc (CBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owners of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 2,406 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 2,406 shares. During the past 18 months, 104,189 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 97,689 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Regado Biosciences Inc do?
Who are the key executives at Regado Biosciences Inc?
Bvf Inc/il is the other: See Explanation of Responses of Regado Biosciences Inc. Other key executives at Regado Biosciences Inc include 10 percent owner Associates Domain , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Christopher Peetz .
Regado Biosciences Inc (RGDO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc (RGDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc (RGDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Regado Biosciences Inc (RGDO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regado Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Palatin Technologies Inc do?
Who are the key executives at Palatin Technologies Inc?
Bvf Inc/il is the 10 percent owner of Palatin Technologies Inc. Other key executives at Palatin Technologies Inc include Executive Vice President & CFO Stephen T Wills , director & President and CEO Carl Spana , and director & Exec. VP Research and Devel. Perry B Molinoff .
Palatin Technologies Inc (PTN) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Palatin Technologies Inc (PTN). Other recent insider transactions involving Palatin Technologies Inc (PTN) include a net sale of 9,997 shares made by Stephen T Wills , a net sale of 5,700 shares made by Deveer Robert K Jr , and a net sale of 200 shares made by Alan W Dunton .
In summary, during the past 3 months, insiders sold 0 shares of Palatin Technologies Inc (PTN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 21,897 shares of Palatin Technologies Inc (PTN) were sold and 6,000 shares were bought by its insiders, resulting in a net sale of 15,897 shares.
Palatin Technologies Inc (PTN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Palatin Technologies Inc Insider Transactions
- Download to Excel(.xls)
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .
In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Neurocrine Biosciences Inc do?
Who are the key executives at Neurocrine Biosciences Inc?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owner of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Regulatory Officer Ingrid Delaet , Chief Scientific Officer Jude Onyia , and Chief Corp. Affairs Officer David W. Boyer .
Neurocrine Biosciences Inc (NBIX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 33,867 shares made by Ingrid Delaet , a net sale of 58,181 shares made by Darin Lippoldt , and a net sale of 55,568 shares made by Julie Cooke .
In summary, during the past 3 months, insiders sold 4,717 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 4,717 shares. During the past 18 months, 997,381 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 997,381 shares.
Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurocrine Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does EPIRUS Biopharmaceuticals Inc do?
Who are the key executives at EPIRUS Biopharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Business Officer Vincent Aurentz , Chief Financial Officer Thomas A. Shea , and director & Chief Executive Officer Amit Munshi .
EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
EPIRUS Biopharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does MediciNova Inc do?
Who are the key executives at MediciNova Inc?
Bvf Inc/il is the 10 percent owner of MediciNova Inc. Other key executives at MediciNova Inc include Chief Financial Officer Jason J Kruger , Chief Financial Officer Douglas Paulin , and Chief Scientific Officer Gaeta Federico C.a. .
MediciNova Inc (MNOV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MediciNova Inc (MNOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MediciNova Inc (MNOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MediciNova Inc (MNOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
MediciNova Inc Insider Transactions
- Download to Excel(.xls)
What does Neurobiological Technologies Inc do?
Who are the key executives at Neurobiological Technologies Inc?
Bvf Inc/il is the 10 percent owner of Neurobiological Technologies Inc. Other key executives at Neurobiological Technologies Inc include 10 percent owner Ariel Warszawski , 10 percent owner Ryan Heslop , and 10 percent owner Firefly Management Co Gp, Llc .
Neurobiological Technologies Inc (NTII) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neurobiological Technologies Inc (NTII) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurobiological Technologies Inc (NTII) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neurobiological Technologies Inc (NTII)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurobiological Technologies Inc Insider Transactions
- Download to Excel(.xls)
What does Dynavax Technologies Corp do?
Who are the key executives at Dynavax Technologies Corp?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owners of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .
Dynavax Technologies Corp (DVAX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 169,000 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 28,587 shares made by Justin Burgess .
In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,747,529 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,747,529 shares.
Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dynavax Technologies Corp Insider Transactions
- Download to Excel(.xls)
What does Repligen Corp do?
Who are the key executives at Repligen Corp?
Bvf Inc/il is the 10 percent owner & other: Group Member of Repligen Corp. Other key executives at Repligen Corp include director & Chief Executive Officer Anthony Hunt , Senior VP & R&D Ralf Kuriyel , and SVP & Global Operations & IT James Bylund .
Repligen Corp (RGEN) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Repligen Corp (RGEN). Other recent insider transactions involving Repligen Corp (RGEN) include a net sale of 81,216 shares made by Anthony Hunt , a net sale of 15,130 shares made by Ralf Kuriyel , and a net sale of 1,850 shares made by Karen A Dawes .
In summary, during the past 3 months, insiders sold 24,246 shares of Repligen Corp (RGEN) in total and bought 0 shares, with a net sale of 24,246 shares. During the past 18 months, 108,357 shares of Repligen Corp (RGEN) were sold and 4,815 shares were bought by its insiders, resulting in a net sale of 103,542 shares.
Repligen Corp (RGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repligen Corp Insider Transactions
- Download to Excel(.xls)
What does Curis Inc do?
Who are the key executives at Curis Inc?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owners of Curis Inc. Other key executives at Curis Inc include CDO Jonathan B. Zung , CFO Diantha Duvall , and Head of Research & Development Robert Martell .
Curis Inc (CRIS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Curis Inc (CRIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Curis Inc (CRIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Curis Inc (CRIS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Curis Inc Insider Transactions
- Download to Excel(.xls)
What does Aeolus Pharmaceuticals Inc do?
Who are the key executives at Aeolus Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owner of Aeolus Pharmaceuticals Inc. Other key executives at Aeolus Pharmaceuticals Inc include President and CEO John L Mcmanus , Chief Financial Officer Russell Skibsted , and 10 percent owner Mark Lappe .
Aeolus Pharmaceuticals Inc (AOLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aeolus Pharmaceuticals Inc (AOLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aeolus Pharmaceuticals Inc (AOLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aeolus Pharmaceuticals Inc (AOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aeolus Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does AMAG Pharmaceuticals Inc do?
Who are the key executives at AMAG Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .
AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMAG Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Arena Pharmaceuticals Inc do?
Who are the key executives at Arena Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owner of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , EVP & Chief Commercial Officer Robert Lisicki , and Executive VP and CBO Vincent Aurentz .
Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arena Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Bvf Inc/il is the 10 percent owner & other: Indirect Beneficial Owner of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 2,000 shares made by Nancy J Hutson , a net purchase of 36,300 shares made by Anthony Doyle , and a net purchase of 30,000 shares made by Helen M. Thackray .
In summary, during the past 3 months, insiders sold 7,000 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 26,987 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 156,614 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XOMA Royalty Corp do?
Who are the key executives at XOMA Royalty Corp?
Bvf Inc/il is the 10 percent owner of XOMA Royalty Corp. Other key executives at XOMA Royalty Corp include Chief Investment Officer Bradley Sitko , director & Interim CEO Owen Hughes , and 10 percent owner Bvf Ii Gp Llc .
XOMA Royalty Corp (XOMAO.PFD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XOMA Royalty Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Royalty Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XOMA Royalty Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Royalty Corp Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 0 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Bvf Inc/il is the 10 percent owner of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Chief Financial Officer Robert E. Gagnon , and Vice President of Finance Daniel Calkins .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 642 shares made by Daniel Calkins , a net sale of 20,890 shares made by Robert E. Gagnon , and a net sale of 6,617 shares made by Dan Paterson .
In summary, during the past 3 months, insiders sold 2,589 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,589 shares. During the past 18 months, 33,265 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,265 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Bvf Inc/il is the 10 percent owner of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Management Llc .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 110,172 shares made by Kevin C Tang ,
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 173,973 shares of Rain Oncology Inc (RAIN) were sold and 284,145 shares were bought by its insiders, resulting in a net purchase of 110,172 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Bvf Inc/il is the 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , director & President and CEO Sean Bohen , and Chief Development Officer David C. Myles .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 334,574 shares made by Cyrus Harmon , a net sale of 2,410,761 shares made by G. Walmsley Graham , and a net sale of 70,436 shares made by David C. Myles .
In summary, during the past 3 months, insiders sold 1,616,447 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 700,761 shares, with a net sale of 915,686 shares. During the past 18 months, 6,819,521 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,946,693 shares were bought by its insiders, resulting in a net sale of 3,872,828 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
- Download to Excel(.xls)
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include Chief Legal Officer Jacquelyn L Sumer , Chief Medical Officer Jeffrey Alan Jones , and See Remarks Jennifer Michaelson .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 98,239 shares made by Jennifer Michaelson , a net sale of 120,000 shares made by Savill Corrine , and a net sale of 6,878 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 24,296 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 24,296 shares. During the past 18 months, 239,564 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 239,564 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Repare Therapeutics Inc do?
Who are the key executives at Repare Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , EVP & Chief Science Officer Michael Zinda , and EVP & Chief Financial Officer Steve Forte .
Repare Therapeutics Inc (RPTX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , a net sale of 13,091 shares made by Lloyd Mitchell Segal , and a net sale of 4,089 shares made by Steve Forte .
In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 21,690 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,989,320 shares.
Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repare Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Bvf Inc/il is the director & 10 percent owner of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & 10 percent owner Biotechnology Value Fund L P , director & Chief Executive Officer Santos Da Silva Jorge , and Chief Scientific Officer Kristian Reich .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net sale of 200,000 shares made by Kristian Reich , a net sale of 184,740 shares made by Santos Da Silva Jorge , and a net purchase of 352,051 shares made by Bihua Chen .
In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 352,051 shares were bought by its insiders, resulting in a net sale of 2,303,689 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
- Download to Excel(.xls)
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and Chief Medical Officer Robert Young Kim .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net sale of 540,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 830,288 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ESSA Pharma Inc do?
Who are the key executives at ESSA Pharma Inc?
Bvf Inc/il is the 10 percent owner of ESSA Pharma Inc. Other key executives at ESSA Pharma Inc include 10 percent owner Biotech Growth N V , Chief Operating Officer Peter Virsik , and director & Chief Executive Officer David Ross Parkinson .
ESSA Pharma Inc (EPIX) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in ESSA Pharma Inc (EPIX). Other recent insider transactions involving ESSA Pharma Inc (EPIX) include a net sale of 81,945 shares made by Peter Virsik , a net purchase of 99,730 shares made by Franklin M Berger , and a net sale of 7,879,583 shares made by Biotech Growth N V .
In summary, during the past 3 months, insiders sold 7,880,277 shares of ESSA Pharma Inc (EPIX) in total and bought 0 shares, with a net sale of 7,880,277 shares. During the past 18 months, 7,961,528 shares of ESSA Pharma Inc (EPIX) were sold and 108,953 shares were bought by its insiders, resulting in a net sale of 7,852,575 shares.
ESSA Pharma Inc (EPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
ESSA Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Third Harmonic Bio Inc do?
Who are the key executives at Third Harmonic Bio Inc?
Bvf Inc/il is the 10 percent owner of Third Harmonic Bio Inc. Other key executives at Third Harmonic Bio Inc include Chief Medical Officer Edward R. Conner , other: See Explanation of Responses Biotechnology Value Fund L P , and Chief Administrative Officer Julie Person .
Third Harmonic Bio Inc (THRD) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 33,970 shares made by Julie Person , a net sale of 14,370 shares made by Edward R. Conner , and a net sale of 25,114 shares made by .
In summary, during the past 3 months, insiders sold 1,004,790 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 1,004,790 shares. During the past 18 months, 1,107,234 shares of Third Harmonic Bio Inc (THRD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,107,234 shares.
Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Third Harmonic Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Structure Therapeutics Inc do?
Who are the key executives at Structure Therapeutics Inc?
Bvf Inc/il is the 10 percent owner of Structure Therapeutics Inc. Other key executives at Structure Therapeutics Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and other: See Explanation of Responses Bvf Ii Gp Llc .
Structure Therapeutics Inc (GPCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc (GPCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc (GPCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Structure Therapeutics Inc (GPCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Structure Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Bvf Inc/il is the 10 percent owner of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .
POINT Biopharma Global Inc (PNT) Insider Trades Summary
Over the past 18 months, Bvf Inc/il made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P ,
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,161,278 shares.
POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
- Download to Excel(.xls)
Bvf Inc/il Mailing Address
Above is the net worth, insider trading, and ownership report for Bvf Inc/il. You might contact Bvf Inc/il via mailing address: 44 Montgomery Street, 40th Fl, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
